Abstract
Ca channel blocker (CCB) is widely used as an anti-hypertensive and anti-ischemic heart disease drug in Japan. CCB or angiotensin receptor antagonist (ARB) is selected as a first line anti-hypertensive drug. However, mono-therapy is often insufficient and combination therapy is needed to achieve the adequate blood pressure control. Hypertensive patients are also sometimes combined with dyslipidemia. In these reasons, a single pill combination of CCB and ARB or statin play an important role in hypertensive and anti-atherosclerotic therapy.
MeSH terms
-
Angiotensin II Type 1 Receptor Blockers / administration & dosage*
-
Antihypertensive Agents / administration & dosage*
-
Calcium Channel Blockers / administration & dosage*
-
Drug Combinations
-
Dyslipidemias / complications
-
Dyslipidemias / drug therapy*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
-
Hypertension / complications
-
Hypertension / drug therapy*
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Antihypertensive Agents
-
Calcium Channel Blockers
-
Drug Combinations
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors